- Home
- ASRV vs CMMB Comparison
ASRV vs CMMB Comparison
Compare ASRV & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRV
- CMMB
- Stock Information
- Founded
- ASRV 1983
- CMMB 2004
- Country
- ASRV United States
- CMMB Israel
- Employees
- ASRV N/A
- CMMB N/A
- Industry
- ASRV Major Banks
- CMMB Biotechnology: Pharmaceutical Preparations
- Sector
- ASRV Finance
- CMMB Health Care
- Exchange
- ASRV Nasdaq
- CMMB Nasdaq
- Market Cap
- ASRV 45.1M
- CMMB 37.3M
- IPO Year
- ASRV N/A
- CMMB N/A
- Fundamental
- Price
- ASRV $2.57
- CMMB $1.71
- Analyst Decision
- ASRV
- CMMB Strong Buy
- Analyst Count
- ASRV 0
- CMMB 2
- Target Price
- ASRV N/A
- CMMB $9.00
- AVG Volume (30 Days)
- ASRV 10.0K
- CMMB 830.9K
- Earning Date
- ASRV 04-15-2025
- CMMB 03-06-2025
- Dividend Yield
- ASRV 4.54%
- CMMB N/A
- EPS Growth
- ASRV N/A
- CMMB N/A
- EPS
- ASRV 0.21
- CMMB N/A
- Revenue
- ASRV $53,139,000.00
- CMMB N/A
- Revenue This Year
- ASRV N/A
- CMMB N/A
- Revenue Next Year
- ASRV N/A
- CMMB N/A
- P/E Ratio
- ASRV $12.52
- CMMB N/A
- Revenue Growth
- ASRV 18.14
- CMMB N/A
- 52 Week Low
- ASRV $2.20
- CMMB $0.58
- 52 Week High
- ASRV $3.06
- CMMB $2.55
- Technical
- Relative Strength Index (RSI)
- ASRV 40.99
- CMMB 32.89
- Support Level
- ASRV $2.54
- CMMB $1.66
- Resistance Level
- ASRV $2.74
- CMMB $2.06
- Average True Range (ATR)
- ASRV 0.14
- CMMB 0.16
- MACD
- ASRV -0.01
- CMMB -0.04
- Stochastic Oscillator
- ASRV 9.68
- CMMB 9.43
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking; wealth management and investment/parent. The company generates maximum revenue from the community banking segment. The community banking segment includes both retail and commercial banking activities. Retail banking includes the deposit-gathering branch franchise and lending to both individuals and small businesses. Lending activities include residential mortgage loans, direct consumer loans and small business commercial loans. Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.